Related Experiment Video
Updated: May 16, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Three cases of IMP-type metallo-β-lactamase-producing Enterobacter cloacae bloodstream infection in Japan
Yohei Hamada1, Koji Watanabe, Tatsuya Tada
1Division of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku, Tokyo, 162-8655, Japan.
Abstract:
We report three cases of IMP-type metallo-β-lactamase-producing Enterobacter cloacae bloodstream infection, which showed minimum inhibitory concentration values for imipenem with 2 μg/ml in all isolates. Although carbapenems were initiated empirically in all cases, two of three cases died. The Clinical and Laboratory Standards Institute lowered the breakpoints of carbapenems for Enterobacteriaceae in 2010. However, the previous breakpoints are still used in many clinical laboratories, which can result in failure to detect carbapenem-resistant Enterobacteriaceae. Therefore, lower breakpoints of carbapenems should be used in clinical settings, and alternative tests for detecting metallo-β-lactamase such as polymerase chain reaction and immunochromatographic assays may contribute to better detection of carbapenem-resistant isolates.
Insights
Three cases of IMP-type metallo-β-lactamase-producing Enterobacter cloacae bloodstream infections highlight challenges in detecting carbapenem resistance. Current laboratory methods may miss these infections, leading to treatment failure and poor outcomes.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Enterobacter cloacae is an opportunistic pathogen that can cause severe bloodstream infections.
- Metallo-β-lactamases (MBLs) confer resistance to a broad range of β-lactam antibiotics, including carbapenems.
- IMP-type MBLs are a significant concern due to their increasing prevalence worldwide.
Observation:
- Three cases of IMP-type MBL-producing Enterobacter cloacae bloodstream infections were identified.
- All isolates exhibited minimum inhibitory concentration values of 2 µg/ml for imipenem.
- Despite empirical carbapenem treatment, two of the three patients died.
Findings:
- The study highlights the potential for carbapenem-resistant Enterobacteriaceae (CRE) to be missed by clinical laboratories using outdated Clinical and Laboratory Standards Institute (CLSI) breakpoints.
- The current CLSI breakpoints for carbapenems may not be sufficiently sensitive to detect all carbapenem-resistant isolates, particularly those with intermediate resistance.
- IMP-type MBL-producing Enterobacter cloacae represents a critical challenge in bloodstream infections.
Implications:
- Lowering carbapenem breakpoints in clinical settings is crucial for accurate detection of carbapenem resistance.
- Implementing alternative detection methods, such as polymerase chain reaction (PCR) and immunochromatographic assays, can improve the identification of MBL-producing isolates.
- Enhanced surveillance and rapid diagnostic strategies are necessary to combat the spread of CRE and improve patient outcomes.
More Related Videos
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
09:44Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
Related Concept Videos
Bacterial Gastroenteritis
Clinical Significance of Antibiotic Resistance
Investigation of Disease Outbreaks
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Endocarditis I: Introduction